๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

โœ Scribed by John G. Krikorian; Carol S. Portlock; Dr. Saul A. Rosenberg

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
359 KB
Volume
41
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

twenty-seven patients with advanced Hodgkin's disease who failed MOPP (nitrogen mustard, vincristine, procarbazine and prednisone) were treated with adriamycin, bleomycin, vinblastine, and imidazole carboxamide, (ABVD). Complete response (CR) was achieved in 22% of patients and partial response was achieved in 15%. No response was observed in 63% of patients. With a median duration of follow-up for CR patients of only 10.5 months, two of the six CR patients have already relapsed. In this series of patients ABVD was not an effective curative regimen for patients with Hodgkin's disease who have failed MOPP.

๐Ÿ“œ SIMILAR VOLUMES

Treatment of MOPP-refractory Hodgkin-s d
Treatment of MOPP-refractory Hodgkin-s disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine
โœ Lawrence H. Einhorn; Stephen D. Williams; Eugene E. Stevens; William H. Bond; Li ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 419 KB ๐Ÿ‘ 1 views

Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD). Fifteen patients had Stage IV d

Treatment of Hodgkin's disease in childr
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy
โœ van den Berg, Henk; Stuve, Wouter; Behrendt, Henk ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 1 views

Since the introduction of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, children with Hodgkin's disease (HD) have been treated with chemotherapy alone. The occurrence of side effects related to irradiation (especially secondary solid tumors) is less likely to occur.

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY
ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY OF HODGKIN'S DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)
โœ J. H. LIPTON; M. GOSPODAROWICZ; S. REINGOLD ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 185 KB

A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of seconda

Hybrid chemotherapy consisting of cyclop
Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease
โœ Silvia Montoto; Mireia Camรณs; Armando Lรณpez-Guillermo; Francesc Bosch; Francisco ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB

## BACKGROUND. Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin disease (HD). Although a prolonged complete response (CR) is achieved in up to 70 -80% of patients, long term complications, such as secondary leukemia, are of concern. C